Efficient production of anti-fluorescein and anti-lysozyme as single-chain anti-body fragments (scFv) by Brevibacillus expression system

Colcher, 1999, Effects of genetic engineering on the pharmacokinetics of antibodies, Q. J. Nucl. Med., 43, 132 Nelson, 2009, Development trends for therapeutic antibody fragments, Nat. Biotechnol., 27, 331, 10.1038/nbt0409-331 Yazaki, 2001, Mammalian expression and hollow fiber biorector production of recombinant anti-CEA diabody and minibody for clinical applications, J. Immunol. Methods, 253, 195, 10.1016/S0022-1759(01)00388-X Accardi, 2010, Antibodies in single-chain format against tumour-associated antigens: present and future applications, Curr. Med. Chem., 17, 1730, 10.2174/092986710791111215 Wörn, 2001, Stability engineering of antibody single-chain Fv fragments, J. Mol. Biol., 305, 989, 10.1006/jmbi.2000.4265 Stockwin, 2003, The role of therapeutic antibodies in drug discovery, Biochem. Soc. Trans., 31, 433, 10.1042/bst0310433 Schmidt, 2009, Fusion-proteins as biopharmaceuticals-applications and challenges, Curr. Opin. Drug Discov. Dev., 12, 284 Makabe, 2005, Tumorpdirected lymphocyte-activating cytokines: refolding-based preparation of recombinant human interleukin-12 and an antibody variable domain-fused protein by additive-introduced stepwise dialysis, Biochem. Biophys. Res. Commun., 328, 98, 10.1016/j.bbrc.2004.12.141 Sharkey, 2005, Perspective on cancer therapy with radiolabeled monoclonal antibodies, J. Nucl. Med., 46, 115S Kelly, 2008, Tumor targeting by a multivalent single-chain Fv (scFv) anti-Lewis Y Antibody construct, Cancer Biother. Radiopharm., 23, 411, 10.1089/cbr.2007.0450 Ottiger, 2009, Efficient intraocular penetration of topical anti-TNF-α single-chain antibody (ESBA105) to anterior and posterior segment without penetration enhancer, Invest. Ophthalmol. Visual Sci., 50, 779, 10.1167/iovs.08-2372 Humphreys, 2001, Therapeutic antibody production technologies: molecules, applications, expression and purification, Curr. Opin. Drug Dev., 4, 172 Andersen, 2004, Production technologies for monoclonal antibodies and their fragments, Curr. Opin. Biotechnol., 15, 456, 10.1016/j.copbio.2004.08.002 Kurucz, 1995, Correct disulfide pairing and efficient refolding of detergent-solubilized single-chain Fv proteins from bacterial inclusion bodies, Mol. Immunol., 32, 1443, 10.1016/0161-5890(95)00105-0 Fursova, 2009, Refolding of scFv mini-antibodies using size-exclusion chromatography via arginine solution layer, J. Chromatogr. B, 877, 2045, 10.1016/j.jchromb.2009.05.038 Tsumoto, 1998, Highly efficient recovery of functional single-chain Fv fragments from inclusion bodies overexpressed in Escherichia coli by controlled introduction of oxidizing reagents-application to a human single-chain Fv fragment, J. Immunol. Methods, 219, 119, 10.1016/S0022-1759(98)00127-6 Fujii, 2007, Stable supply of large amounts of human Fab from the inclusion bodies in E. coli, J. Biochem., 141, 699, 10.1093/jb/mvm075 Kudou, 2011, A novel protein refolding system using lauroyl-l-glutamate as a solubilizing detergent and arginine as a folding assisting agent, Protein Expr. Purif., 75, 46, 10.1016/j.pep.2010.08.011 Kudou, 2011, Refolding single-chain antibody (scFv) using lauroyl-l-glutamate as a solubization detergent and arginine as a refolding additive, Protein Expr. Purif., 7, 68, 10.1016/j.pep.2010.12.007 Adachi, 1989, Multiple and tandemly arranged promoters of the cell wall protein gene operon in Bacillus brevis 47, J. Bacteriol., 171, 1010, 10.1128/jb.171.2.1010-1016.1989 Mizukami, 2010, Brevibacillus expression system: host-vector system for efficient production of secretory proteins, Curr. Pharm. Biotechnol., 11, 251, 10.2174/138920110791112031 Tokunaga, 2013, Secretory production of single-chain antibody (scFv) in Brevibacillus choshinensis using novel fusion partner, Appl. Microbiol. Biotechnol., 20 Tsumoto, 1994, Effect of the order of antibody variable regions on the expression of the single-chain HyHEL10 Fv fragment in E. coli and the thermodynamic analysis of its antigen-binding properties, Biochem. Biophys. Res. Commun., 201, 546, 10.1006/bbrc.1994.1736 Midelfort, 2004, Substantial energetic improvement with minimal structural perturbation in a high affinity mutant antibody, J. Mol. Biol., 343, 685, 10.1016/j.jmb.2004.08.019 Sagiya, 1994, Direct high-level secretion into the culture medium of tuna growth hormone in biologically active form by Bacillus brevis, Appl. Microbiol. Biotechnol., 42, 358 Shiga, 1992, Characterization of an extracellular protease inhibitor of Bacillus brevis HPD31 and nucleotide sequence of the corresponding gene, Appl. Environ. Microbiol., 58, 525, 10.1128/AEM.58.2.525-531.1992 Ejima, 2005, Arginine as an effective additive in gel permeation chromatography, J. Chromatogr. A, 1094, 49, 10.1016/j.chroma.2005.07.086